International journal of general medicine · 2026
Restaging pN Classification in Early Gastric Cancer with Inadequate Lymph Node Retrieval: Multi-Institutional Development and Prognostic Validation of a Revised Staging System.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nie Xinyang, Li Gang, Liu Zhiqiang, Ke Bin, Yang Zuli, Ye Zaisheng, Zhang Tao, Wang Xiangyu, Yang Kun, You Qi, Zhou Tong, Li Yong, Zhang Rupeng, Ren Peng, Wang Wei, Tian Yantao, Zhang Kecheng, Deng Jingyu
Аннотация
OBJECTIVE: This study aimed to propose and validate a new and practical lymph node (LN) staging strategy to mitigate staging migration due to examined LN (ELN) retrieval and improve the accuracy of prognostic evaluation for early gastric cancer (EGC) patients.
BACKGROUND: EGC patients often face staging inaccuracies due to inadequate ELNs, as there is no clear standard for ELN retrieval requirements.
METHODS: From an initial cohort of 7001 EGC patients across fifteen large institutions in China, 6566 eligible patients were included as the training and validation cohort after applying predefined exclusion criteria. We analyzed these data to determine the optimal cutoff value for the number of ELNs, construct a prediction model, and propose a new LN staging method distinct from that of the latest AJCC guidelines. Subsequently, 2094 patients (from 2326 with survival data available in the multicenter dataset) and 1944 patients (from 5262 initially retrieved from the SEER database after exclusions) were included as independent test cohorts to evaluate model performance, including the correlation between ELNs and metastatic LNs (MLNs) and survival differences.
RESULTS: This study found that ≤20 ELNs were inadequate for accurate LN evaluation in EGC patients. In the test cohort, MLNs was positively associated with ELNs. A model was constructed, and accurate MLNs could be displayed after correction for patients with inadequate ELNs. Survival analysis revealed significant differences between patients with different pNM (pN modified) stages in both the multicenter test cohort and the SEER test cohort.
CONCLUSION: Model-corrected pNM staging may improve staging migration and survival prediction than the AJCC staging, showing great clinical applicability for EGC patients with ELN ≤ 20.
BACKGROUND: EGC patients often face staging inaccuracies due to inadequate ELNs, as there is no clear standard for ELN retrieval requirements.
METHODS: From an initial cohort of 7001 EGC patients across fifteen large institutions in China, 6566 eligible patients were included as the training and validation cohort after applying predefined exclusion criteria. We analyzed these data to determine the optimal cutoff value for the number of ELNs, construct a prediction model, and propose a new LN staging method distinct from that of the latest AJCC guidelines. Subsequently, 2094 patients (from 2326 with survival data available in the multicenter dataset) and 1944 patients (from 5262 initially retrieved from the SEER database after exclusions) were included as independent test cohorts to evaluate model performance, including the correlation between ELNs and metastatic LNs (MLNs) and survival differences.
RESULTS: This study found that ≤20 ELNs were inadequate for accurate LN evaluation in EGC patients. In the test cohort, MLNs was positively associated with ELNs. A model was constructed, and accurate MLNs could be displayed after correction for patients with inadequate ELNs. Survival analysis revealed significant differences between patients with different pNM (pN modified) stages in both the multicenter test cohort and the SEER test cohort.
CONCLUSION: Model-corrected pNM staging may improve staging migration and survival prediction than the AJCC staging, showing great clinical applicability for EGC patients with ELN ≤ 20.